SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : wla(warner lambert)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ibexx who wrote (717)4/27/1999 8:53:00 PM
From: Captain Jack   of 942
 
Ibexx------ WLA being put into bonds type investment by ML could be very good news-- this too

ARSIPPANY, N.J., April 27 (Reuters) - Warner-Lambert
Co.'s (WLA - news) incoming chief executive said Tuesday the
drug and consumer health-care group is financially strong enough
to pursue other companies and products, but he would not say if
it had any immediate acquisition plans.

Speaking on the sidelines at Warner-Lambert's annual meeting, incoming chairman and chief
executive Lodewijk de Vink said the company is still in a regulatory ''quiet period'' because of its
pending $2.1 billion acquisition of Agouron Pharmaceuticals Inc. (AGPH - news).

Since AGPH was interested in IMNR could that be on the mind of WLA??
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext